Project Details
Description
A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter- Consortium Collaborative Study
Status | Finished |
---|---|
Effective start/end date | 9/1/10 → 9/15/14 |
Funding
- UNIVERSITY OF WISCONSIN-MADISON
- NIH NATIONAL CANCER INSTITUTE (NCI)